| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
|
Asakura, Masanori
|
|
2017
|
31 |
4 |
p. 401-411
|
artikel
|
| 2 |
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis
|
Awad, Kamal
|
|
2017
|
31 |
4 |
p. 419-431
|
artikel
|
| 3 |
Erratum to: Vasodilator Therapy: Nitrates and Nicorandil
|
Tarkin, Jason M.
|
|
2017
|
31 |
4 |
p. 483
|
artikel
|
| 4 |
Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy
|
Lu, Jing
|
|
2017
|
31 |
4 |
p. 367-379
|
artikel
|
| 5 |
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
|
Yang, Hayang
|
|
2017
|
31 |
4 |
p. 413-417
|
artikel
|
| 6 |
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216
|
Reijers, Joannes A. A.
|
|
2017
|
31 |
4 |
p. 381-389
|
artikel
|
| 7 |
Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
|
Povsic, Thomas J.
|
|
2017
|
31 |
4 |
p. 445-458
|
artikel
|
| 8 |
Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus
|
Purga, Scott L.
|
|
2017
|
31 |
4 |
p. 459-470
|
artikel
|
| 9 |
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
|
Dobesh, Paul P.
|
|
2017
|
31 |
4 |
p. 433-444
|
artikel
|
| 10 |
The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety
|
Flaten, Hania K.
|
|
2017
|
31 |
4 |
p. 471-482
|
artikel
|
| 11 |
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials
|
Brugts, J. J.
|
|
2017
|
31 |
4 |
p. 391-400
|
artikel
|
Tijdschrift beschrijving